NDAINJECTIONINJECTABLEPriority Review
Approved
Dec 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PIPRACIL (piperacillin sodium) is an injectable broad-spectrum beta-lactam antibiotic used to treat serious bacterial infections. It is typically administered intravenously or intramuscularly for hospitalized patients with moderate to severe infections. The drug works by inhibiting bacterial cell wall synthesis, making it bactericidal against a wide range of gram-positive and gram-negative organisms.
LOE Approaching
LOE-approaching lifecycle suggests declining team investment and potential workforce optimization in coming years.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PIPRACIL careers are concentrated in operational and commoditized commercial functions rather than innovation-driven roles. The LOE-approaching lifecycle suggests limited growth trajectory and potential cost-reduction focus for teams managing this mature injectable product.
Supply Chain ManagerCommercial Operations Analyst
Worked on PIPRACIL at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.